TSE:9987 (Japan)
Business Description
Suzuken Co Ltd
8 Higashi Kataha-machi, Higashi-ku, Nagoya, JPN, 461-8701
Compare
Compare
Traded in other countries / regions
ZU1.Germany
•
9987.Japan
•
SZUKF.USA
Description
Suzuken Co Ltd is a Japanese drug manufacturer. It functions through four segments: Pharmaceutical Wholesale, which sells pharmaceuticals, diagnostic drugs, and medical equipment and materials; The Pharmaceutical Manufacturing, which produces pharmaceuticals and diagnostic drugs; The Insurance Pharmacy dispenses operations based on prescriptions from medical institutions and the Medical-related Service and Others segment which sells medical books, provides nursing services and manufactures physiological examination equipment.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.36 | |||||
Interest Coverage | 421.4 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.9 | |||||
Beneish M-Score | 0 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.6 | |||||
3-Year EBITDA Growth Rate | -15.4 | |||||
3-Year EPS without NRI Growth Rate | -20.3 | |||||
3-Year Book Growth Rate | 2.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.21 | |||||
9-Day RSI | 35.56 | |||||
14-Day RSI | 36.06 | |||||
6-1 Month Momentum % | 6.4 | |||||
12-1 Month Momentum % | 16.97 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.25 | |||||
Quick Ratio | 1.05 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 25.2 | |||||
Days Sales Outstanding | 86.24 | |||||
Days Payable | 121.78 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.13 | |||||
Dividend Payout Ratio | 0.36 | |||||
3-Year Dividend Growth Rate | 6.9 | |||||
Forward Dividend Yield % | 2.13 | |||||
5-Year Yield-on-Cost % | 3.02 | |||||
3-Year Average Share Buyback Ratio | 1.2 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 7.38 | |||||
Operating Margin % | 0.84 | |||||
Net Margin % | 0.78 | |||||
ROE % | 4.18 | |||||
ROA % | 1.48 | |||||
ROIC % | 3.98 | |||||
ROC (Joel Greenblatt) % | 23.04 | |||||
ROCE % | 6.16 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 17.28 | |||||
PE Ratio without NRI | 17.03 | |||||
Shiller PE Ratio | 15.19 | |||||
PS Ratio | 0.13 | |||||
PB Ratio | 0.72 | |||||
Price-to-Tangible-Book | 0.74 | |||||
Price-to-Operating-Cash-Flow | 31.73 | |||||
EV-to-EBIT | 3.68 | |||||
EV-to-EBITDA | 3.68 | |||||
EV-to-Revenue | 0.04 | |||||
EV-to-FCF | -20.29 | |||||
Price-to-Projected-FCF | 0.63 | |||||
Price-to-Median-PS-Value | 0.8 | |||||
Price-to-Graham-Number | 0.75 | |||||
Price-to-Net-Current-Asset-Value | 1.95 | |||||
Earnings Yield (Greenblatt) % | 27.18 | |||||
Forward Rate of Return (Yacktman) % | -1.84 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 2,245,426 | ||
EPS (TTM) (円) | 198.201 | ||
Beta | 0.16 | ||
Volatility % | 20.02 | ||
14-Day RSI | 36.06 | ||
14-Day ATR (円) | 77.089705 | ||
20-Day SMA (円) | 3605.25 | ||
12-1 Month Momentum % | 16.97 | ||
52-Week Range (円) | 2963 - 3985 | ||
Shares Outstanding (Mil) | 87.94 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Suzuken Co Ltd Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |